172 related articles for article (PubMed ID: 3449808)
1. Opioid mechanisms of some behavioral effects of ketamine.
Fidecka S
Pol J Pharmacol Pharm; 1987; 39(4):353-60. PubMed ID: 3449808
[TBL] [Abstract][Full Text] [Related]
2. Interactions of ketamine, naloxone and morphine in the rat.
Fidecka S
Pol J Pharmacol Pharm; 1987; 39(1):33-40. PubMed ID: 3671186
[TBL] [Abstract][Full Text] [Related]
3. Interaction between ketamine and ethanol in rats and mice.
Fidecka S; Langwiński R
Pol J Pharmacol Pharm; 1989; 41(1):23-32. PubMed ID: 2587434
[TBL] [Abstract][Full Text] [Related]
4. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL
J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011
[TBL] [Abstract][Full Text] [Related]
5. Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.
Tortella FC; Moreton JE; Khazan N
J Pharmacol Exp Ther; 1979 Aug; 210(2):174-9. PubMed ID: 222892
[TBL] [Abstract][Full Text] [Related]
6. A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Ren X; Noda Y; Mamiya T; Nagai T; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):243-50. PubMed ID: 15196791
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
8. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin 4 deficiency modulates morphine pharmacological actions.
Wu N; Lu XQ; Yan HT; Su RB; Wang JF; Liu Y; Hu G; Li J
Neurosci Lett; 2008 Dec; 448(2):221-5. PubMed ID: 18973795
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of opioid analgesic tolerance in p75 neurotrophin receptor null mutant mice.
Trang T; Koblic P; Kawaja M; Jhamandas K
Neurosci Lett; 2009 Feb; 451(1):69-73. PubMed ID: 19114089
[TBL] [Abstract][Full Text] [Related]
11. Effects of taurine on tolerance to and dependence on morphine in mice.
Contreras E; Tamayo L
Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):224-31. PubMed ID: 6538778
[TBL] [Abstract][Full Text] [Related]
12. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
[TBL] [Abstract][Full Text] [Related]
13. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
14. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
Kreeger JS; Larson AA
J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
[TBL] [Abstract][Full Text] [Related]
15. Modification of morphine tolerance by behavioral variables.
Sannerud CA; Young AM
J Pharmacol Exp Ther; 1986 Apr; 237(1):75-81. PubMed ID: 3958974
[TBL] [Abstract][Full Text] [Related]
16. Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
Lange DG; Roerig SC; Fujimoto JM; Busse LW
J Pharmacol Exp Ther; 1983 Jan; 224(1):13-20. PubMed ID: 6681541
[TBL] [Abstract][Full Text] [Related]
17. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
Cichewicz DL; Welch SP
J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
[TBL] [Abstract][Full Text] [Related]
18. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
Lamas X; Farre M; Cami J
J Pharmacol Exp Ther; 1994 Mar; 268(3):1485-92. PubMed ID: 8138958
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
Naidu PS; Singh A; Joshi D; Kulkarni SK
Addict Biol; 2003 Sep; 8(3):327-36. PubMed ID: 13129835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
